Bactiguard Holding AB’s (publ) Annual General Meeting

At Bactiguard Holding AB’s (publ) Annual General Meeting on May 21, the
following resolutions were made:

  · The Annual General Meeting adopted the income statement and balance sheet
for 2014.

  · It was decided that no dividend for the financial year 2014 will be paid and
that the company's loss (for the year) will be carried forward.

  · The Board of Directors and CEOs were discharged from liability for the
financial year 2014.

  · The Annual General Meeting decided that an annual remuneration of SEK
150 000 will be paid to each of the regular board members and an amount of SEK
300 000 be paid to the chairman of the Board. Furthermore it was decided that no
remuneration will be paid for work on committees of the Board. Provided that it
is cost-neutral for the company, remuneration may be invoiced through a wholly
-owned company of a director.

  · The Board members Christian Kinch (chairman) and Mia Arnhult were re-elected
and Stanley Brodén and Peter Hentschel were elected as new Board members.
Christian Kinch was re-elected as the chairman of the Board.

  · The Annual General Meeting decided to re-elect Deloitte AB, as auditor.
Remuneration to the auditors shall be paid according to approved invoice.

  · The Annual General Meeting resolved to amend the articles of association,
making it possible to hold shareholder meetings, in addition to in Stockholm
where the Board has its registered seat – in Huddinge or Botkyrka, in the
vicinity of Bactiguard’s new headquarters.

  · The Annual General Meeting adopted the Nomination Committee’s proposal for
Instructions for the Nomination Committee.

  · The proposed guidelines for compensation and other employment terms for
senior management were adopted.

This is information that Bactiguard Holding AB (publ) is required to publish in
compliance with the Swedish Securities Market Act and/or the Financial
Instruments Trading Act. The information was submitted for publication on 21 May
2015, at 16.30.
For further information, please contact:
Cecilia Edström, Acting Director of Sales, Marketing & Communications, mobile:
+46 722 262 328
About Bactiguard
Bactiguard is a Swedish medtech company with a mission of preventing healthcare
associated infections, reducing the use of antibiotics and saving lives by
developing and supplying infection prevention solutions for the healthcare
industry. The company’s patented coating prevents healthcare associated
infections by reducing bacterial adhesion and growth on medical devices.
Bactiguard®-coated urinary catheters are market leading in the US and Japan, and
in recent years the company has developed its own product portfolio of catheters
for the urinary and respiratory tract and the blood stream. Bactiguard is
currently in a strong expansion phase, focused on new markets in the Europe,
Middle East, Asia, Latin America and Southern Africa. The company has market
presence in some 50 countries and has about 60 employees. Its headquarters is
located in Stockholm and production facilities in Sweden and Malaysia.
Bactiguard is listed on Nasdaq Stockholm. Read more about Bactiguard at
www.bactiguard.com